BFEC
RPRX

Benjamin F. Edwards & Company’s Repros Therapeutics Inc. RPRX Stock Holding History

Benjamin F. Edwards & Company’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,700
Closed -$2K – 1743
2017
Q4 		$2K Hold
2,700
– – ﹤0.01% 1524
2017
Q3 		$1K Hold
2,700
– – ﹤0.01% 1528
2017
Q2 		$1K Hold
2,700
– – ﹤0.01% 1448
2017
Q1 		$3K Hold
2,700
– – ﹤0.01% 1267
2016
Q4 		$4K Hold
2,700
– – ﹤0.01% 1110
2016
Q3 		$6K Hold
2,700
– – ﹤0.01% 938
2016
Q2 		$4K Hold
2,700
– – ﹤0.01% 956
2016
Q1 		$3K Hold
2,700
– – ﹤0.01% 1007
2015
Q4 		$3K Hold
2,700
– – ﹤0.01% 1054
2015
Q3 		$20K Buy
+2,700
New +$20.6K ﹤0.01% 726

Benjamin F. Edwards & Company's RPRX Position: Q1 2018 in Review

Benjamin F. Edwards & Company sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 2,700 shares — an estimated $2K sold.

Benjamin F. Edwards & Company first reported a position in RPRX in Q3 2015 and held it in 10 quarters. The position peaked at $20K in Q3 2015. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

  • Benjamin F. Edwards & Company reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 2,700 Repros Therapeutics Inc. shares in Q1 2018, an estimated $2K.
  • Benjamin F. Edwards & Company first reported a position in Repros Therapeutics Inc. in Q3 2015 and held it in 10 quarters.
  • Benjamin F. Edwards & Company's Repros Therapeutics Inc. position peaked at $20K in Q3 2015.
  • 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2018, filed 17 Apr 2018.